China trial shows gum tissue stem cells help 55% of lifetime diabetes patients

Song Guo Zheng, who was imprisoned in the US during Trump’s China Initiative, continues his research with promising early clinical results

More than half of those who received the treatment showed varying degrees of improvement, while one subject was able to discontinue exogenous insulin therapy completely, the researchers said.